Investors Title (NASDAQ:ITIC – Get Free Report) was the target of a significant growth in short interest during the month of October. As of October 31st, there was short interest totalling 26,300 shares, a growth of 41.4% from the October 15th total of 18,600 shares. Currently, 1.9% of the company’s stock are sold short. Based on an average trading volume of 14,100 shares, the short-interest ratio is currently 1.9 days.
Investors Title Stock Performance
Shares of NASDAQ ITIC traded down $3.18 during mid-day trading on Friday, hitting $271.60. The stock had a trading volume of 10,867 shares, compared to its average volume of 10,692. The company has a 50 day moving average of $235.29 and a two-hundred day moving average of $204.10. Investors Title has a twelve month low of $141.41 and a twelve month high of $283.27. The firm has a market cap of $511.69 million, a PE ratio of 17.97 and a beta of 0.85.
Investors Title Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Monday, December 16th. Investors of record on Monday, December 2nd will be given a $14.46 dividend. The ex-dividend date is Monday, December 2nd. This represents a $57.84 dividend on an annualized basis and a yield of 21.30%. This is a positive change from Investors Title’s previous quarterly dividend of $0.46. Investors Title’s dividend payout ratio is currently 12.18%.
Institutional Investors Weigh In On Investors Title
Analyst Upgrades and Downgrades
Separately, StockNews.com downgraded shares of Investors Title from a “buy” rating to a “hold” rating in a report on Thursday.
Check Out Our Latest Stock Analysis on ITIC
Investors Title Company Profile
Investors Title Company engages in the issuance of residential and commercial title insurance for residential, institutional, commercial, and industrial properties. The company underwrites land title insurance for owners and mortgagees as a primary insurer; and assumes the reinsurance of title insurance risks from other title insurance companies.
Recommended Stories
- Five stocks we like better than Investors Title
- 5 Top Rated Dividend Stocks to Consider
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- Compound Interest and Why It Matters When Investing
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- Why Are Stock Sectors Important to Successful Investing?
- Time to Load Up on Home Builders?
Receive News & Ratings for Investors Title Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Investors Title and related companies with MarketBeat.com's FREE daily email newsletter.